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ABSTRACT 
 This is a comprehensive project for the development of a general method to enhance 
the sensitivity of DNA aptasensors by coupling them with an isothermal DNA amplification 
technique known as exponential amplification reaction (EXPAR).  The method involves two 
steps: (1) first, the target-induced structure-switching of DNA aptamers causes the release of 
trigger oligonucleotides from the aptamers immobilized on a surface; (2) then, the released 
trigger oligonucleotides are amplified by the EXPAR technique for ultrasensitive detection.  It is 
shown that the detection limit of a cocaine aptasensor is improved from 5 micromolar in assays 
without amplification to 0.8-1micromolar when EXPAR is applied, providing a 5-fold 
enhancement.  The flexibility in designing the sequences of the trigger oligonucleotides enables 
the method generally applicable to other aptasensor systems such as thrombin aptamers.  By 
EXPAR, the method has also achieved 10-fold enhancement in sensitivity from 4nM to 400 pM 
for thrombin detection, in comparison with similar assays without EXPAR.   
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CHAPTER 1 
INTRODUCTION 
 A sensor is a device or molecule that responds to a chemical or physical stimulus, and 
converts that response to a measureable signal.  To ensure in the health, safety and comfort of 
our society, sensors of all types have been critical and widely used for medical diagnosis, food 
safety and environmental monitoring. (1)  With respect to these applications, various analytes 
throughout environment and biology are targeted and evaluated.  Among many, these analytes 
include metal ions, toxins, viruses and small molecules. (1-5)  
Some examples of the current technologies used to measure these analytes include 
High pressure liquid chromatography (HPLC) and Gas chromatography-Mass spectrometry (GC-
MS).(1)  These methods are used to separate different chemical compounds in a material in 
order to identify and quantify the substances within the material of interest, therefore 
providing a means of detection for specific targets.  One advantage of using methods like these 
includes the high sensitivity they are capable of, sometimes down to parts per billion or less of 
a specific target.  Also, they provide a standard for industries and have the ability to detect 
different targets simultaneously.  However, the usage of these technologies also gives some 
disadvantages that are not desirable in some cases.  One disadvantage is the requirement of 
highly sophisticating equipment needed to provide such high sensitivities.  In addition, in these 
methods there is also a need for timely and costly sample pretreatment and professional 
personnel to carry out measurement and data analysis.  These disadvantages make it 
impossible to provide the public with a portable and easy-to-use method to monitor the targets 
of interest.  On the other hand, due to the growing need for real-time, on-site and in situ 
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detection of many targets, the development of a general method for the sensitive and selective 
recognition of a broad range of targets has also become of great importance for scientist in all 
fields, to avoid the complicated trial-and-error to develop different methods for different 
targets. (5) 
 In order to develop a general method for the ultrasensitive detection of a target of 
interest, a high quality sensor must be incorporated and utilized within the design of the overall 
method.  A high quality sensor that can be converted into an efficient tool for detection will 
have many characteristics that must be accounted for.  This sensor will be simple to handle and 
have a rapid analysis, being able to provide the user with a result very quickly and easily.  It will 
be unsusceptible to its environment enabling its usage in a variety of locations and situations, 
portable to allow for detection on the go, and be highly sensitive and selective to its target.  
Also, a high quality sensor will have a tunable dynamic range to provide the ability to detect 
targets with a wide range of concentrations and most importantly be cost-effective.  Most 
technologies used today integrate sensors which carry some of these features but not all of 
them together.  So there is a need for a general method which uses a high quality sensor that 
combines all of these features into one and provides us with rapid, ultrasensitive and real-time 
detection and quantification for a broad range of targets.    
  
 
 
2 
 
CHAPTER 2 
FUNCTIONAL DNA AND PERFORMANCE ENHANCING 
 One material that has been shown to not only be used as a sensor but also exhibits all of 
the qualities necessary to be considered a high quality sensor is a specific type of 
Deoxyribonucleic acid (DNA), known as Functional nucleic acids or also known as Functional 
DNA. (4-10)  Since the discovery of functional nucleic acids in the early 90’s, many have realized 
their potential as major components in the realm of biosensing. (4-6, 11)   With this potential, DNA 
has launched itself out of its traditional spotlight of genetic information carrier, and into its 
newly pronounced operative role for environmental, pharmaceutical and biochemical 
applications. (4-6, 11)  Functional DNA are a group of oligonucleotides consisting of aptamers, 
DNA enzymes (or known as DNAzymes or deoxyribozymes) and aptazymes with functions 
beyond the conventional roles of DNA as a genetic information carrier. (4-6, 11, 12)  Using a 
combinatorial technique called in vitro selection or Systematic evolution of ligands by 
exponential enrichment (SELEX), nucleic acid sequences that exhibit catalytic behavior 
(DNAzymes), specifically bind to a target (aptamers), or both (aptazymes) have been developed. 
(4-6, 8-9)  With in vitro selection, a desired target is incubated with a large random nucleic acid 
pool containing 1014-1016 different sequences.  Nucleic acid sequences that bind to the target 
are preserved while unbound sequences are removed using an affinity column immobilized 
with the target of choice.  Next, the sequences that have bound to the target are eluted and 
amplified using polymerase chain reaction (PCR). (13)  This cycle is repeated, and after many 
positive and negative selection rounds with increasingly stringent conditions, nucleic acid 
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sequences with a high binding affinity and specificity towards that desired target are obtained. 
(13)  Through this procedure of in vitro selection, nucleic acids with the ability to change 
conformation and/or perform catalytic reactions at its core in the presence of specific 
inorganic, organic, biomolecules and even bacteria, cancel cells or viruses has been obtained 
and utilized for analyte detection (Simple demonstration along with table of targeting species 
exhibited in Figure 1 and Table 1). (11)  Shown in Figure 2 is a depictive image of in vitro selection 
and examples of the end results of the active DNA with the corresponding molecule or target 
that is selective for that nucleic acid.   
Functional DNA provides the platform for a high quality sensing device that can be 
incorporated into a general method for the detection of a target of choice.  The basic 
characteristics of DNA are what make it attractive as a sensing device and allow for us to take 
advantage of in order to generate the high quality sensor. (6)  The predictable Watson-Crick base 
pairing interactions give flexibility to the design of the overall sensor. (6)  The low cost synthesis 
of DNA with a range of chemical modifications that can be used for the attachment of and 
utilization of assisting materials offers the means for a cost-effective detection method.  Also, 
the high stability of DNA through hydrogen bonding and the fact that it can be denatured and 
renatured readily without losing its characteristics and ability to perform its designated duties 
has made DNA a highly capable material to integrate into a sensing technology. (11)  Being that 
there is an established procedure for the synthesis of functional DNA that will be active towards 
a specific target of choice, the possibilities of targets to employ functional DNA for detection 
purposes are almost endless.   
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Functional DNA performing target recognition consists of one part of the sensing 
mechanism.(4-9)  The second, signal transduction, can be easily achieved through the 
incorporation of fluorophores, quenchers and other signal transducing materials through 
various well known bioconjugation techniques.  Because of the unique characteristics of 
materials such as the optical properties of Au nanoparticles (NP), the fluorescent emission of 
fluorophores and the reduction of fluorescent signal by quenchers, the target recognition 
process performed by functional DNA can be quantified and analyzed to determine the amount 
of a specific target is present in a given environment. (11)  With the functional DNA responding 
to the physical stimuli of a specific target being recognized, and the signal transducing materials 
turning that response into a measurable quantity, functional DNA can be employed as sensors 
with tunable dynamic ranges for small analyte targets.  With functional DNA based sensors, 
binding events are transduced into signals proportional to the concentration of analyte present 
in the system.  These signals can thus be analyzed by the fluorescence, color, electric and 
magnetic properties that are associated with their specific transducing materials. (11)    To give a 
complete picture, by combining functional DNA with certain materials that have very distinct 
properties, a sensing device that is not only selective and non-interfering with its target, but is 
also one that is cost efficient and readily available can be engineered.  Functional DNA provides 
the platform for further studies to increase the number of target choices and overall 
capabilities of these types of sensors.   
Many different detection methods have been developed based on target recognition in 
functional DNA and the corresponding response to physical stimuli.  In this case, the stimulus is 
the target and the response is the catalytic behavior of the enzymatic core in DNAzymes and/or 
5 
 
the structure switching conformational change of the ssDNA in DNA aptamers. (11)   With the 
generation of these nucleic acids in vitro, they can be engineered to have high selectivity to 
fundamentally any preferred molecule. (11)  Also, being that the manipulation of DNA has been 
well researched and documented, signal transducing elements can be easily incorporated into 
the DNA sequence therefore satisfying the second requirement of a sensor device.  Ultimately, 
we can obtain many types of signals including fluorescent, color, electric and magnetic 
dependant on the choice of integrated materials.   Ongoing research with functional DNA-based 
sensors has resulted in many effective and reliable detection methods for a number of targets 
including environmental contaminants such as Pb2+ (8, 14), radioactive species such as uranyl 
(UO22+) (15), and small organic molecules of interest such as cocaine (16-19) and adenosine. (20)  
Examples of two different functional DNA based sensors developed for the detection of Pb2+ 
using different signal reporters is shown in Figure 3. (8, 14)  Despite the pronounced success of 
these types of sensing technologies, the increasingly extreme and stringent sensitivity 
requirements needed to satisfy personal, environmental, and governmental standards have 
limited the usage of functional DNA-based sensors in forensic and clinical applications.  In 
general, though functional DNA provides a great platform for the responsive and discriminatory 
detection of a vast range of analytes, there is still a need for performance enhancement of 
these systems. 
Functional DNA based sensors are a great start but do not quite provide us with a 
powerful enough tool for detection and quantification of targets of interest for forensic and 
clinical applications.  With the current limits of detection (LOD) functional DNA based sensors 
offer for various molecules and species there is a need for sensor performance enhancement.  
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Being that functional DNA was discovered in the 90s, there have been ongoing and exhausting 
efforts on the improvement of these biosensors and their performance. (4-9, 11)  One way in 
which performance has been progressed is through the coupling of already established 
procedures with these sensors.  Due to the nature of functional DNA-based sensors, that being 
the inclusiveness and manipulation of nucleic acids, the amplification of DNA has become a 
valuable asset in the improvement of such systems. (21)  In these systems, the amplification of 
DNA generates an increase in signal resulting in an enhancement of the overall performance of 
that system.  Owing to the fact that isothermal DNA amplification is a more cost-effective, rapid 
and simple method than the more established thermocycling technique of polymerase chain 
reaction (PCR), it has become a prime candidate for the performance enhancement of 
functional DNA based sensors. (22-31)  In isothermal DNA amplification the amount or 
concentration of DNA is amplified through means of a DNA polymerase at a constant high 
temperature. (21)  Isothermal DNA amplification is highly sensitive and selective and does not 
require thermally stable DNA polymerases or sophisticated equipment.  These properties make 
the coupling and compatibility of this amplification method with functional DNA-based sensors 
a more facile process.  By coupling this technique with functional DNA based sensors, one is 
able to increase the amount of DNA present in the environment which will then increase the 
amount of signal being reported to the transducing materials, thus enhancing the performance 
of the sensor, decreasing the LOD and increasing the overall sensitivity of the sensing device. (32)  
This entire process of using functional DNA based sensors that can be generated to detect 
essentially any molecule of choice and coupling them with isothermal DNA amplification to 
enhance the LODs of that sensor provides a general methodology that in future projects can be 
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incorporated into a device for rapid, ultrasensitive, real-time, on-site and in situ detection of 
harmful and/or helpful targets of interest. 
There have been many procedures established for isothermal DNA amplification.  Some 
of those include Loop-mediated Isothermal Amplification (LAMP) in which a DNA polymerase 
and four turn back primers recognize six distinct DNA sequences (22, 23); Rolling Circle 
Amplification (RCA) in which a circular template is replicated hundreds to thousands of times; 
(24) Strand Displacement Amplification (SDA) in which a restriction endonuclease is employed to 
‘nick’ a single bond in a DNA backbone and subsequently cause the release of a short single 
DNA strand. (25)   Each of these methods has its advantages, and some such as RCA have been 
used alongside aptamers for the ultrasensitive detection of targets such as ATP (Adenosine 
Triphosphate) (26), platelet-derived growth factor (PDGF) (26), and cocaine. (31)   Though some of 
the LOD’s using isothermal DNA amplification techniques have reach low numbers, the time at 
which the assay takes place is too long in some cases and the ability to create an exponential 
reaction which can provide yet lower LOD’s is absent with these techniques.  Therefore, the 
development of a rapid and general ultrasensitive detection method for a broad range of 
targets, using functional DNA-based sensors enhanced with isothermal DNA amplification is still 
a challenge that needs to be met. 
One way in which this challenge can be met is through the coupling of isothermal 
Exponential Amplification Reaction (EXPAR) with established functional DNA based sensors.  
EXPAR is a molecular chain reaction wherein the products of one reaction catalyze further 
reactions that generate the same products.  It is an isothermal DNA amplification method in 
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which short ssDNA 10-25 nucleotides long are multiplied 106 times in less than five minutes. (27-
30)  This is accomplished through the employment of a DNA polymerase, a nicking enzyme, and 
a DNA template of simple design.  When a trigger oligonucleotide (DNA strand to be amplified) 
is introduced into the system, a transient duplex is formed with the complementary DNA 
template.  This transient duplex serves as the primer and activates the DNA polymerase.  Once 
the recognition sequence is polymerized, the restriction endonuclease (nicking enzyme) is 
activated and hydrolyzes only one strand of the DNA duplex. (33)  When this happens, the half of 
the DNA duplex is now below its critical length and the newly formed ssDNA releases from the 
transient duplex to become the reactant for further replication, thus creating an exponential 
effect (EXPAR shown in Figure 4).  This effect can be quantified based on the time at which the 
amplification takes place and intercalating DNA dyes.  The higher the starting concentration of 
DNA the faster the timing of the amplification will take place.  Being that the DNA polymerase 
and nicking enzyme operate optimally at the same temperatures the reaction in entirely is 
performed at that temperature.  The only requirements for the design of the EXPAR method is 
that the template must contain the recognition site which is contingent to the nicking enzyme 
of choice, 9 base pairs of cDNA on both sides of the recognition site and 3’ blocking with either 
PO4 groups or tethered Amines.  These simple requirements enable easy coupling of the 
amplification system with functional DNA based sensing systems.  By using aptamer structure 
switching mechanisms and solid supports for bioseparation, it is possible to couple the two 
procedures of target detection and isothermal DNA amplification, allowing for an ultrasensitive 
detection method that ultimately lowers the already established LOD for the functional DNA 
based sensor used for that target without any performance enhancers. 
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CHAPTER 2 FIGURES AND TABLES 
M(II)
A: DNAzyme
Substrate
Enzyme
B: Aptamer
+
M(II)
C: Aptazyme
 
Figure 1.  Functional nucleic acids as targeting agents  
Examples of functional DNA performing  A. catalytic reactions (DNAzyme), B. changing conformation 
(aptamer) or C. both in the presence of analyte targets (aptazyme) 
Figure adapted from Lu Lab files and information obtained in: 
Liu J, Cao Z, Lu Y, “Functional nucleic acid sensors”, Chem. Rev., 2009, 109, 1948-1998    
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Contaminant type Examples 
Metal Ions Pb2+, Cu2+, Hg2+, As5+, Zn2+ 
Radionucleotides UO22+ 
Toxins Ricin, Abrin toxin, Microcystin 
Antibiotics Vasopressin, Streptomycin, Tetracycline, 
Viomycin, Chloramphenicol 
Endocrine disrupting compounds and hormones 17β-estradiol, Thyroxine hormone 
Protein HA 1 proteins or H5N1 influenza virus, Thrombin 
Other small organic molecules Cocaine, cholic acid, (R)-thalidomide, 
Ethanolamine 
Cells and bacteria Anthrax spores, Campylobacter jejuni 
 
Table 1.  Analytes targeted by functional DNAs 
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 Figure 2.  In vitro selection and examples of functional DNAs 
Left: Schematic overview of in vitro selection process 
Right: Examples of finished product of in vitro selection for DNAzymes (Pb2+, UO22+) and DNA aptamers 
for small molecule adenosine and protein thrombin  
Figure adapted from: 
 Liu J, Cao Z, Lu Y, “Functional nucleic acid sensors”, Chem. Rev., 2009, 109, 1948-1998    
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 Figure 3.  Functional DNA sensors for Pb2+ 
Left: Fluorescent based DNAzyme sensor for Pb2+ ion and resulting graph 
Right: Colorimetric based DNAzyme sensor for Pb2+ ion and resulting graphs  
Figure adapted from: 
 Liu J, Cao Z, Lu Y, “Functional nucleic acid sensors”, Chem. Rev., 2009, 109, 1948-1998   
Liu J, Lu Y, “Improving Fluorescent DNAzyme Biosensors by Combining Inter- and Intramolecular 
Quenchers”, Anal. Chem., 2003, 75, 6666-6672  
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Figure 4.  Exponential Amplification Reaction (EXPAR) 
Schematic overview of Exponential Amplification reaction  
Figure adapted from: 
Tan E, Wong J, Nguyen D, Zhang Y, Erwin B, Van Ness LK, Baker SM, Galas DJ, Niemz A, “Isothermal DNA 
amplification coupled with DNA nanosphere-based colorimetric detection”, Anal. Chem., 2005, 77, 7984-
7992    
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CHAPTER 3 
METHODOLOGY 
Herein is the presentation of a general method for the enhancement of the LOD of the 
DNA Aptasensors for small molecule cocaine and the protein thrombin.  The overall procedure 
for performance enhancement is achieved in three steps.  For the detection of cocaine the first 
step (1) is sensor preparation which involves the bioconjugation of the functional DNA to a solid 
support.  Due to the high binding affinity and selectivity of biotin-streptavidin interactions, a 
biotin labeled aptamer was conjugated to the solid surface of a streptavidin coated magnetic 
bead (MB).  Multiple rounds of washing are performed to remove unbound DNA, followed by 
the hybridization of a complementary DNA strand (Trigger X) to the aptamer (Figure 5A).  More 
washes are executed to assist in the reduction of background noise present from unhybridized 
Trigger X being present.  The next step (2) commences with the introduction of the solutions 
containing different concentrations of the cocaine target into the system.  The aptamer then 
undergoes a structure switching process due to its binding with the target.  This leads to the 
release of Trigger X from the MB/aptamer complex and with magnetic separation, trigger X can 
be easily removed from the system for subsequent reactions. The final step (3) is the insertion 
of Trigger X into the EXPAR master mixes for simultaneous amplification and quantification of 
Trigger X.  With this procedure, fluorescence spectroscopy is used for the analysis of Trigger X 
production by an intercalating dye SYBR Green II, which in turn allows us to assign a LOD based 
on the time at which Trigger X is amplified.  The LOD using this procedure is justified by the 
theory that the higher the concentration of the target present in solution, the higher the 
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concentration of Trigger X that will be released from the complex for insertion into the EXPAR 
system and thus the faster the time of amplification will occur.   
There are two keys to the success of this procedure.  First, by using magnetic beads we 
allow for a fast and facile way to separate Trigger X from the detection system and combine it 
with the amplification system.  Second is the design and operation of Trigger X.  Being that the 
EXPAR template will amplify a specific single nucleic acid we can use that feature to create a 
Trigger X sequence that will couple the two systems and enable optimization of both systems 
separately and simultaneously.  The Trigger X for this procedure is a single DNA strand 
specifically designed to be compatible in both the detection system and the amplification 
system.  It contains a short 10-14 nucleotide DNA sequence complementary to the cocaine 
aptamer (cDNA) and a 10 nucleotide DNA sequence to be used in EXPAR (AmpDNA) separated 
by a poly(A)6 linker.  The design of Trigger X (Figure 5B) provides flexibility in the design of the 
detection scheme and also avoids interrupting the thermodynamic stability of the AmpDNA to 
the template during the formation and extension of the transient duplex in the EXPAR scheme.  
This allows for generalization of the detection system to perform optimization of the system 
and for utilizing other aptamers for the detection of different targets of interest. 
The sensor preparation consisted of determining how many base pairs on the Trigger X 
species would allow for optimum background reduction and release of Trigger X.  It contained 
experiments utilizing the streptavidin-coated MBs, biotin labeled cocaine aptamers and FAM 
labeled Trigger X DNA sequences with varying lengths and positions of complementary 
nucleotides (Figure 6).  This experiment was done for target recognition of the conjugated 
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functional DNA and Trigger X optimization and is successful because of the quenching effect 
magnetic beads have on a fluorophore (FAM in our case) and because of the Trigger X release 
from the MB/Aptamer complex due to structure switching.  These phenomena’s along with the 
predictability provided through Watson-Crick base pairing allow for our system to be evaluated 
accordingly.  Once the cocaine target is presented to the MB/aptamer complex and a 
conformational change occurs, the FAM labeled Trigger X will exhibit an increase in its 
fluorescence intensity.  This increase is then quantified based on the initial fluorescence 
intensity provided by the overall complex before the addition of the target.  The entire 
preparation of the sensor along with the detection of cocaine is performed in one buffer 
termed Detection Buffer (50 mM Tris/ 150 mM NaCL/ 0.05% Tween 20/ pH = 7.15).  To start the 
sensor preparation, MBs are washed with the detection buffer twice.  Then the streptavidin 
coated MBs are incubated with biotin labeled DNA aptamer for 30 minutes.  By using magnetic 
separation the MB/Aptamer complex is washed two more times with the detection buffer, and 
incubated with 2µM Trigger X for 1 hour.  Next, the complete sensor complex being the 
MB/Aptamer/Trigger X is washed three more times to remove any excess Trigger X.  Finally, the 
addition of cocaine containing detection buffer enables a fluorescent readout dependant on 
the amount of target present.  At this point, the initial LOD is determined via 3Ϭ plus the 
average of blank to ensure comparison with similiar methods and targets in current literature 
and to provide a base line for the assessment of performance enhancement.   
The ability to amplify the newly designed Trigger X via EXPAR was evaluated to ensure 
the designs functionality in the EXPAR system.  This evaluation was performed in the 
designated master mixes according to the enzymes used (Bst and Nt.BstNBI) and previous 
17 
 
literature. (27-30)  Each master mix, mix A [1X NEBuffer 3 (50 mM Tris-HCl/ 100 mM NaCL/ 5 mM 
MgCL2/ 1 mM Dithiothreitol/ pH = 7.9), 2.4 mM EGTA, 500uM dNTPs, 200 nM X’-X’ DNA 
Template, and the mixed in Trigger X] and mix B [1X DNA Polymerase Buffer (20 mM Tris-HCl/ 
10 mM (NH4)2SO4/ 10 mM KCl/ 2 mM MgSO4/ 0.1 % Triton X-100/ pH 8.8), 0.8 unit/mL 
Nt.BstNBI nicking enzyme, 0.16 unit/mL Bst DNA polymerase, 1X SYBR Green II dye] was 
prepared in an ice bucket directly before mixing.  SYBR Green II dye is used as the signal 
tranducing material.  To initiate the reaction, Trigger X is diluted into Mix A.  Next, equal 
amounts of Mix A and Mix B are mixed together and immediately placed into the heating 
chamber where the samples are preheated for 75 seconds prior to analysis.  Measurements are 
taken in 5 second intervals for a total of 5 minutes and the entire reaction takes place at 55 ⁰C. 
To complete the entire procedure for the ultrasensitive detection of cocaine, the sensor 
complex is prepared and the target is recognized same as described previously.  After target 
recognition, Trigger X is removed from the MB/Aptamer complex by magnetic separation and 
diluted 25X into millipore H2O and then 10X into Mix A.  This dilution is done to provide 
minimum interference of any materials present from the detection system to the amplification 
system.    Next, the Trigger X containing Mix A is combined with an equal volume of Mix B.   
Finally the system is heated to activate amplification, and analyzed.  The total assay time for the 
detection of the target and amplification of Trigger X is less than 30 minutes.  The LOD for the 
overall method of target recognition and amplification is calculated and compared to the LOD 
for the detection system alone.  This LOD is calculated similarly to the LOD with the FAM 
labeled Trigger X, except since it is based on the point of infections (PoI) of the amplification of 
Trigger X, which decrease with increasing analyte concentration, it is defined as three times the 
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standard deviation of the blank minus the concentration of analyte required to give a signal 
equal to the background (blank) sample.  
In order to establish the generalization of this overall method the thrombin aptamers 
were chosen to demonstrate the ‘sandwich’ based detection of thrombin with a slightly 
different procedural design and minimum modification of the Trigger X used.  Instead of using 
MBs, a neutravidin coated 96 well plate was used as the solid support and the biotin labeled 
aptamer was replaced with the desthiobiotin labeled thrombin aptamer (15mer).  This allowed 
for the release of the thrombin sensing complex from the plate which is then inserted into the 
EXPAR system for amplification.  The Trigger X design was similar to the cocaine procedure in 
that it contained a 10 nucleotide sequence complementary to the same DNA template and a 
poly(A)6 linker.  The difference in this procedure was the use of the 29mer thrombin aptamer 
linked to the AmpDNA instead of the cDNA to the cocaine aptamer.  In this procedure, the 
desthiobiotin labeled 15mer thrombin aptamer would bind to the neutravidin coated plates 
through the strong avidin-biotin interaction.  After rounds of washing to remove unbound 
sequences, the complex is then exposed to solutions containing different concentrations of 
thrombin.  The higher the concentration of thrombin, the more target loading will take place 
onto the complex.  Next, the Trigger X containing the 29mer thrombin aptamer is added to the 
solution and after structure switching and conformational changes of the 29mer thrombin 
aptamer a sandwich complex of the thrombin between the two aptamers is present along with 
the AmpDNA for the following EXPAR reaction.  This complex is then immersed with a biotin 
containing solution releasing it from the plates.  Finally this solution containing the entire 
complex including the AmpDNA is inserted into the EXPAR system for amplification and 
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quantification of the concentration of target present.   The evaluation of target recognition is 
accomplished similarly to the cocaine procedure with a FAM labeled Trigger X species.  The 
presence of thrombin increases the load amount of FAM labeled Trigger X and subsequent 
releasing of the sensing complex results in a spike in fluorescence intensity of the solution.  The 
ratio of initial fluorescence of the solution prior to releasing to final fluorescence intensity of 
the solution after releasing provides a measure of target recognition.  The amplification of the 
Trigger X being used in this procedure is evaluated exactly the same way as in the cocaine 
procedure.     
The DNA used for both procedures was purchased from IDT DNA Technologies, while 
the components of the master mixes including buffers, Bst DNA polymerase and the Nt.BstNBI 
Nicking Enzyme were all purchased from New England Biolabs in Ipswich, MA.  The magnetic 
beads were purchased from Bangs Laboratories, the neutravidin coated plates were purchased 
from Thermo Scientific and all other reagents were from Sigma.  Experiments were done on a 
FluoroMax-P fluorimeter (HORIBA Jobin Yvon Inc., Edison, NJ) fit with a heating chamber and an 
Analyst HT at the High Throughput Screening Facility of the School of Chemical Sciences in 
Noyes Laboratory at the University of Illinois at Urbana-Champaign.  
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CHAPTER 3 FIGURES AND TABLES 
Figure 5.  Overall procedure for cocaine detection and Trigger X design 
  
A. Overall step-wise procedure for target detection and amplification of Trigger X  
 
B. Trigger X design and key points to Trigger X model 
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Figure 6.  Target recognition and Trigger X optimization 
 
Schematic of aptamer target recognition and subsequent structure switching and release of FAM-
labeled Trigger X 
Four different DNA sequences (X12, X13C, X13T, X14) for Trigger X optimization containing varying 
lengths and locations of extra nucleotides (enlarged and in Bold) and poly (A)6 linker (underline) 
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CHAPTER 4 
RESULTS AND DISCUSSION 
 For the cocaine detection system to be successful it is important to find the optimal 
conditions for proper loading of the aptamer onto the solid surface and for efficient 
hybridization of the cDNA with the aptamer.  With incorrect or inadequate preparation of the 
device, the activity of the aptamer can be lost.  In accordance with this, different conditions 
were tested for the hybridization of cDNA and target recognition of cocaine.  To evaluate our 
sensor’s performance when using only the detection probe without EXPAR, we used a FAM 
labeled Trigger X, which upon release from the MB/Aptamer complex produces a fluorescence 
signal in solution.  Figure 7 shows the results of using the four differently sequenced cDNAs 
based on varying lengths and positions of nucleotides shown in Figure 6.  Using four different 
sequences of Trigger X makes it possible to probe the balance between the low background and 
high sensitivity of our device, and thus improving our sensor performance.  All the Trigger X 
sequences shown in Figure 7 show little and similar background intensity (0 µM cocaine).  
However, Trigger X sequences X13C and X14 contain an extra base pair on the cocaine aptamer 
sequence and show a decrease in sensor performance.  Trigger X sequences X12 and X13T 
contain none or 1 base pair on the PolyA linker and show an increase in sensor performance.  
Therefore, adding complementary DNA base pairing to the cocaine aptamer sequence 
decreased sensor performance and in order to preserve and/or enhance performance, 
additions to the cDNA must be made to the 3’ side of the DNA sequence.   To provide a 
performance evaluation of the detection system prior to DNA amplification, Figure 8 shows the 
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graphs of the increase in fluorescence intensity as well as the background to signal ratio of the 
system using X13T as our Trigger X with the addition of increasing cocaine concentration.  As 
the concentration of cocaine in the micro molar range is increased, the fluorescent intensity of 
the system is increased as well.  These results show that optimization of our detection system 
in regards to the balance between a low background noise and a high sensitivity is achieved and 
a dynamic range for the sensor is obtained.  Overall, the performance of our detection system 
is comparable to similar technologies that use fluorescence based analyses of cocaine with a 
LOD = ~5µM.  The limit of detection is defined by the concentration of analyte required to give 
a signal equal to the background (blank) sample plus three times the standard deviation of the 
blank.  By using a calibration curve the concentration LOD is calculated from the best fit line 
equation. 
The ability to amplify Trigger X with conventional EXPAR conditions and also with the 
EXPAR conditions needed for our system was performed.  In our system, Trigger X is coming 
from the detection buffer and must be diluted into our master mixes.  This is a concern because 
of the sensitivity of the enzymes used in EXPAR.  Figure 9 represents the graph of a typical 
EXPAR experiment in which the time at which amplification occurs is dependent on the 
concentration of Trigger X13T present in the system.  As the concentration of Trigger X13T is 
increased from 10pM to 10nM, the time at which that sample is amplified increases 
proportionately.  For high accuracy and resolution of the amplification, a plot of PoIs 
corresponding to maximum slope of the fluorescence curves is also shown in Figure 9.  Through 
EXPAR we achieved amplification of AmpDNA only and Trigger X13T (cDNA + PolyA6 + AmpDNA) 
down to pM levels.  Due to the amount of Trigger X being released from our detection scheme, 
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pM amplifications of Trigger X is more than sufficient to amplify the DNA from our detection 
system.  The amplification of Trigger X13T diluted in the buffer used for the detection steps is 
still attainable as shown in Figure 9. 
Performing the overall procedure simply consists of target recognition and Trigger X release, 
followed by magnetic separation and Trigger X introduction into master mixes.  Through this 
process, we are able to successfully couple a detection system with an amplification system.  
Shown in Figure 10, as the concentration of cocaine is increased from 0-500µM, the time at 
which the sample is amplified increases.  To clarify, the blank sample on this graph represents 
an EXPAR performed without the addition of any solution from the detection system, while the 
0µM is an EXPAR performed with the addition of the blank sample from the detection scheme 
(no cocaine added to the MB/Aptamer complex).  Figure 10 also contains the corresponding PoI 
graph.  The LOD for cocaine for the overall procedure described herein is calculated to be 
~800nM-1µM giving a 5X enhancement in the LOD for this aptamer and target versus the 
method without using amplification.  This LOD is calculated similarly to the LOD with the FAM 
labeled Trigger X, except since it is based on the PoIs of the amplification of Trigger X13T, which 
decrease with increasing analyte concentration, it is defined as three times the standard 
deviation of the blank minus the concentration of analyte required to give a signal equal to the 
background (blank) sample.   
Using the procedure described for the thrombin detection, the target recognition was 
successful and the performance of the functional DNA based sensor yielded a LOD = 4nM, 
which is also comparable to current technologies used for these aptamers and target without 
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any amplification.  The graphs shown in Figure 11 show the spike in fluorescence intensity and 
also an increase in the background to signal ratio with increasing concentrations of thrombin 
from 0-500nM and provides a dynamic range for this sensing device.  The amplification of the 
Trigger X for the thrombin detection method [Thrombin Aptamer(29) + PolyA6 + AmpDNA] was 
also successful as shown in Figure 12 by amplifying concentrations of the Trigger X down to the 
low pM range.  The amplification of this Trigger X which contains 38 non-active nucleotides 
confirms that this type of Trigger X model can be utilized for enhancing other functional DNA 
based sensors and provides generalization within the procedural designs for other targets.  The 
overall procedure with the target recognition of thrombin and the amplification of the DNA 
after being released from the plates was accomplished as shown in Figure 13.  Using the PoI 
graph the LOD for this overall method is calculated to be 400pM which give a 10X enhancement 
over the initial detection system.     
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CHAPTER 4 FIGURES AND TABLES 
Figure 7.  Trigger X optimization.   
 
 
Top: Graph of fluorescence intensity increase of different FAM labeled Trigger X’s with increasing 
[cocaine] = 0-50µM 
Bottom: Graph of background to signal ratio of same Trigger X’s with increasing [cocaine] 
 Experiment performed with 1mg/mL of Magnetic beads, 1.75µM biotin labeled cocaine aptamer, 2µM 
FAM-lebeled Trigger X and 30 minute incubation with buffer containing varying [cocaine] 
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Figure 8.  Trigger X13T performance  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Top: Graph of fluorescence intensity increase of Trigger X (X13T) with increasing [cocaine] = 0-500µM 
Bottom: Graph of background to signal ratio of same Trigger X with increasing [cocaine] = 0-500µM 
 Experiment performed with 1mg/mL of Magnetic beads, 1.75 µM biotin labeled cocaine aptamer, 2µM 
FAM-labeled Trigger X and 30 minute incubation with buffer containing varying [cocaine] 
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Figure 9.  Trigger X13T amplification via EXPAR and corresponding PoI graph  
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Top: Graph of fluorescence intensity vs. time for varying [Trigger X13T]  
Bottom: Graph of Inflection points corresponding to maximum slope of the fluorescence curves from 
top graph  
Experiment performed by combing equal amounts of master mixes A and B and diluting Trigger X13T 
with millipore water to obtain its desired concentration prior to its insertion into master mix A.  Samples 
analyzed for 5 minutes at 55°C with fluorescence excitation of 490nm and emission 520nm 
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Figure 10.  Overall procedure: EXPAR of Trigger X13T released from sensor complex  
 
 
 
 
 
 
 
 
 
 
 
Top: Graph of fluorescence intensity vs. time for Trigger X13T obtained from target induced structure 
switching of cocaine aptamer containing varying [cocaine], 0-500µM  
Bottom: Graph of Inflection points corresponding to maximum slope of the fluorescence curves from 
top graph  
Experiment performed with same parameters of detection step and amplification step described in 
figures 8 and 9.  Analysis done at 55°C for 5 minutes with fluorescence excitation of 490nm and emission 
520nm 
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Figure 11.  Thrombin target recognition schematic and performance  
 
 
Top: Schematic of 
thrombin induced 
‘sandwich’ formation 
showing binding of 
FAM-labeled Trigger X 
and subsequent release 
of Trigger X 
Middle: Graph of 
increasing fluorescence 
intensity signal of FAM 
labeled Trigger X with 
increasing [Thrombin) = 
0-500nM 
Bottom: Graph of 
background to signal 
ratio of same Trigger X 
with increasing 
[Thrombin] = 0-500nM 
Experiment performed 
on opaque neutravidin 
coated plates with 1.5 
µM biotin labeled 
15mer aptamer and 
1.5nM FAM-labeled 
Trigger X with 29mer 
aptamer.  Solutions 
incubated with 1mM 
biotin for 30 minutes 
and buffer containing 
varying [thrombin] for 
30 minutes 
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Figure 12.  Thrombin Trigger X amplification via EXPAR  
 
 
 
 
 
 
 
 
 
 
  
Graph of Inflection points corresponding to maximum slope of the fluorescence curves obtained from 
fluorescence intensity vs. time with varying [Trigger X]   
Experiment performed by combing equal amounts of master mixes A and B and diluting Trigger X with 
millipore water to obtain its desired concentration prior to its insertion into master mix A.  Samples 
analyzed for 5 minutes at 55°C with fluorescence excitation of 490nm and emission 520nm 
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Figure 13.  Overall procedure (Thrombin): EXPAR of Trigger X released from sensor complex  
 
 
 
 
 
 
 
 
 
Top: Graph of fluorescence intensity vs. time for Trigger X released after target induced binding of 
thrombin and Trigger X aptamer containing varying [thrombin], 0-500nM  
Bottom: Graph of Inflection points corresponding to maximum slope of the fluorescence curves from 
top graph  
Experiment performed with same parameters of detection step and amplification step described in 
figures 11 and 12.  Analysis done at 55°C for 5 minutes with fluorescence excitation of 490nm and 
emission 520nm 
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CHAPTER 5 
CONCLUSIONS 
The system described here is a new method for the ultrasensitive detection of a target 
species using aptasensors based on exponential amplification reaction (EXPAR).  It combines 
the highly selective and sensitive target recognition from aptamers with the rapid and facile 
DNA amplification of EXPAR and the total assay from target introduction to readout takes less 
than 30 minutes.  With the general design of this system, the choice of aptamer is not limited 
and its activity can be maintained and optimized without disturbing the DNA amplification 
reaction that follows.  It is proven that the aptamer maintains its activity after immobilization 
onto a solid surface, and that the design of the system enables optimizations of both target 
recognition by aptamer and DNA amplification by EXPAR.  A key concept to this project is the 
careful yet simple design of the Trigger X which is incorporated into both systems.  Trigger X is 
designed for utilization in the detection system and to provide a trigger for activation of the 
amplification system.  This model of Trigger X allows for the systems to be coupled and 
optimized.  As a proof of concept, a cocaine aptamer was chosen for target recognition of a 
small molecule.  In the presence of cocaine, a structure switching process takes place which 
then releases an oligonucleotide complementary to the aptamer of choice (Trigger X).  By using 
a FAM labeled Trigger X, we have shown that our detection system without coupling it to the 
performance enhancer has an LOD consistent with similar systems previously published (5µM in 
our case). (20)  We also show that the isothermal amplification via EXPAR of our Trigger X which 
is designed so that it would be functional in both systems is achieved down to picomolar 
34 
 
concentrations.  The coupling of the detection system with the amplification system is 
demonstrated with a LOD for cocaine of 800nM to 1µM, which is five times lower than the 
detection system alone without EXPAR.  This work is the first to use this type of model of 
Trigger X to couple both systems.  The cocaine detection system employs an aptamer structure 
switching model which depends on DNA hybridization.  To exhibit the generalization of this 
method, changing to a target recognition system that utilizes a binding mechanism, similar to 
that in the thrombin binding aptamers, was also successfully coupled and provided a ten times 
enhancement to the LOD from 4nM to 400pM using performance enhancing amplification.  This 
change was as simple as making a minor adjustment to the procedure to account for the 
change in the introduction of Trigger X to the amplification system, and slight adjustments to 
the Trigger X which did not compromise the original model design.  This design of Trigger X 
showed that with as many as 38 non-active nucleotides, EXPAR of the trigger DNA is still 
maintained and reproducible.   
For future efforts another minor modification that can be made to the system is the 
introduction of gold nanoparticles (AuNPs) for an ultrasensitive colorimetric detection method.  
This is accomplished through the incorporation of a second DNA template during the EXPAR 
scheme. (30)  The second template translates the AmpDNA to another DNA strand that can serve 
as a bridging oligonucleotide for aggregating AuNPs and resulting in a color change from red to 
blue.  The employment of this method into our system would be as easy as adding in the 
second template to the master mix prior to the addition of the Trigger X into the system.  We 
anticipate that with these additions to our system, a general methodology for real-time, on-site 
and ultrasensitive detection of a wide range of targets is in the near future.  
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